| SZ CAT No: | CL-NMSF-04 |
| CAS No: | 66-86-4 |
| Mol.F: | C23H46N6O13 |
| Mol.Wt.: | 614.7 |
| Chemical Name: | (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol |
| SMILES: | NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H]3O)[C@H](N)[C@@H](O)[C@@H]1O |
| Inventory Status: | Custom synthesis |
This impurity is related to Neomycin Sulfate EP Impurity C is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Neomycin Sulfate EP Impurity C is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diolCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Neomycin Sulfate Molecular Formula: C23H46N6O13
Molecular Weight: 614.7
Storage: Store in a cool, dry place.
Cat. No: CL-NMSF-01
CAS No: 1405-10-3
Mol. F: C23H46N6O13 : H2SO4
Mol. Wt: 614.7 : 98.1
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-02
CAS No: 3947-65-7
Mol. F: C12H26N4O6
Mol. Wt: 322.4
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-03
CAS No: NA
Mol. F: C14H28N4O7
Mol. Wt: 364.4
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-05
CAS No: 534-47-4
Mol. F: C12H25N3O7
Mol. Wt: 323.4
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-06
CAS No: 1263-89-4
Mol. F: C23H45N5O14 : H2SO4
Mol. Wt: 615.6 : 98.1
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-07
CAS No: 51795-47-2
Mol. F: C23H45N5O14
Mol. Wt: 615.6
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-08
CAS No: 54631-94-6
Mol. F: C25H48N6O14
Mol. Wt: 656.7
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-09
CAS No: 28002-70-2
Mol. F: C23H46N6O13 : X(H2O4S)
Mol. Wt: 614.7 : X(98.1)
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-10
CAS No: 7542-37-2
Mol. F: C23H45N5O14
Mol. Wt: 615.6
Inv. Status: Custom Synthesis
.jpg)
Cat. No: CL-NMSF-11
CAS No: 52433-41-7
Mol. F: C12H24N2O8
Mol. Wt: 324.3
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-13
CAS No: 78524-73-9
Mol. F: C23H45N5O14
Mol. Wt: 615.6
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-14
CAS No: 78549-66-3
Mol. F: C23H45N5O14
Mol. Wt: 615.6
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-16
CAS No: 78524-72-8
Mol. F: C23H44N4O15
Mol. Wt: 616.6
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-17
CAS No: 4146-30-9
Mol. F: C23H46N6O13 : 3(H2SO4
Mol. Wt: 614.7 : 3(98.1)
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-18
CAS No: NA
Mol. F: C17H34N4O10
Mol. Wt: 454.5
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-19
CAS No: NA
Mol. F: C11H22N2O7
Mol. Wt: 294.3
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-20
CAS No: NA
Mol. F: C6H14N2O4
Mol. Wt: 178.2
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-21
CAS No: NA
Mol. F: C11H22N2O8
Mol. Wt: 310.3
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-22
CAS No: 55781-25-4
Mol. F: C17H33N3O11
Mol. Wt: 455.5
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-23
CAS No: 108864-61-5
Mol. F: C6H14N2O4
Mol. Wt: 178.2
Inv. Status: Custom Synthesis
Cat. No: CL-NMSF-24
CAS No: 527-10-6
Mol. F: C6H14N2O4
Mol. Wt: 178.2
Inv. Status: Custom Synthesis
| CAT No: | CL-NMSF-04 |
| CAS No: | 66-86-4 |
| Mol.F: | C23H46N6O13 |
| Mol.Wt: | 614.7 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: